BIONIK Laboratories Corp. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

TECHNOLOGY AND OTHER ASSETS

TECHNOLOGY AND OTHER ASSETS

6 Months Ended

Sep. 30, 2019

4. TECHNOLOGY AND OTHER ASSETS

The schedule below reflects the intangible assets acquired in the IMT acquisition and the assets amortization period and expense for the six months ended September 30, 2019, and the year ended March 31, 2019:


	Amortization	Value	Amortization	Value at	Amortization	Value at
	period (years)	Acquired	March 31, 2019	March 31, 2019	September 30, 2019	September 30, 2019
Intangible assets acquired		$	$	$	$	$
Patents and exclusive License Agreement	9.74	1,306,031	134,090	911,440	67,044	844,396
Trademark	Indefinite	2,505,907	—	2,505,907	—	2,505,907
Customer relationships	10	1,431,680	143,168	1,010,375	71,584	938,791
Non compete agreement	2	61,366	1,739	—	—	—
Assembled workforce	1	275,720	—	—	—	—
		5,580,704	278,997	4,427,722	138,628	4,289,094

Amortization expense for the technology and other assets was $138,628 and $140,368 for the six months ended September 30, 2019 and 2018, respectively.

Amortization expensed for the technology and other assets was $69,314 and $69,315 for the three months ended September 30, 2019 and 2018, respectively.